Astrazeneca vaccine

New Delhi assures Dhaka it would help get US vaccines on priority basis, says minister

Older patients who have been assigned AstraZeneca are also demanding a different vaccine

AstraZeneca’s vaccine is by far the cheapest and most high-volume shot launched so far

Temporary suspension does not mean that the vaccine is unsafe or ineffective

Relationship between vaccine, blood clots not confirmed, more studies needed, says WHO advisory committee

The university said in February it planned to enroll 300 volunteers aged 6-17 years, based in the United Kingdom

Investigators have not confirmed a causal link with the Covid-19 AstraZeneca vaccine, investigations ongoing

Four previously healthy individuals who got the AstraZeneca shot and developed life-threatening clots

Europe has so far approved vaccines from Pfizer/BioNTech, Moderna and AstraZeneca/Oxford

AstraZeneca vaccine’s efficacy in preventing infections was 70.4%, compared with Pfizer/BioNTech's efficacy of 95%

Scheme’s promoters say programme is struggling from lack of funds, supply risks and complex contractual arrangements

Pfizer Inc sought emergency-use authorisation in India, followed by Astra Zeneca’s Covishield vaccine

Both Covid-19 vaccines have more work to do to confirm whether their Covid-19 vaccine can be 90% effective

Remarks came after international biopharmaceutical company AstraZeneca stopped vaccine trials in four countries

AstraZeneca’s shot is widely considered the leading candidate after results from human trials showed it was safe